MEGAN GALLERANI: Open Payments
NPI 1417366642 · CORTLAND, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$659 in 31 payments from 14 companies in 2025. Trend: 2023 $194 · 2024 $561 · 2025 $659
Food & beverage: $659
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $102 |
| ABBVIE INC. | 4 | $92 |
| AstraZeneca Pharmaceuticals LP | 4 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $75 |
| GlaxoSmithKline, LLC. | 4 | $69 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $46 |
| Lilly USA, LLC | 2 | $42 |
| Exact Sciences Corporation | 1 | $32 |
| Janssen Pharmaceuticals, Inc | 1 | $29 |
| Corium, LLC | 1 | $23 |
Products named: Kerendia, AIRSUPRA, VRAYLAR, TRELEGY ELLIPTA, Rybelsus, JARDIANCE, The Cologuard Plus Collection Kit, SPRAVATO.
Industry payments across NY — which companies pay providers there.
